Skip to Content

Dinutuximab

In the US, Dinutuximab (dinutuximab systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Neuroblastoma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC16

CAS registry number (Chemical Abstracts Service)

1363687-32-4

Chemical Formula

C6514-H10154-N1752-O2029-S50

Molecular Weight

147078

Therapeutic Categories

Immunomodulator

Antineoplastic agent: Monoclonal antibody

Chemical Names

gamma1 heavy chain (1-443) [Mus musculusVH (IGHV1S135*01 -(IGHD)-IGHJ4*01) [8.8.6] (1-113) -Homo sapiensIGHG1*03 (CH1 (114-211), hinge (212-226), CH2 (227-336), CH3 (337-441), CHS (442-443)) (114-443)], (216-220')-disulfide with kappa light chain (1'-220' (WHO)

Immunoglobulin G1-kappa, anti-ganglioside GD2, chimeric monoclonal antibody (WHO )

Foreign Names

  • Dinutuximabum (Latin)
  • Dinutuximab (German)
  • Dinutuximab (French)
  • Dinutuximab (Spanish)

Generic Names

  • Dinutuximab (OS: USAN)
  • Ch14.18 (IS)
  • UNII-7SQY4ZUD30 (IS)

Brand Name

  • Unituxin (pediatric)
    United Therapeutics, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide